Richmond Pharmacology’s Research Director Dr Radivoj Arezina has written a piece for the July edition of GMP Review ‘ The application of GMP and its role in maximising the benefits of adaptive study design in early phase clinical trials’
The full article can be read here.
I am very pleased with the Project Management of both studies undertaken on behalf of (blank) and any future studies we have to outsource will automatically be contracted to you.
- Anonymous
Many thanks for your time today, most impressed with the quality of the follow up to our enquiry.
- Anonymous
Please know that it has been an absolute pleasure collaborating with you and that I am most appreciative of the key contributions RPL has made to this project thus far. I hope I have the opportunity to work with RPL again in the very near future.
- Anonymous
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing
Read more ›Richmond Pharmacology update on SARS-CoV-2 infection control and management of clinical trials
Read more ›Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are
Read more ›Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON
View event ›
+44 (0) 20 7042 5800
